Impedimed (ASX:IPD) YoY EPS Growth : -20.00% (As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Impedimed YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Impedimed's YoY EPS Growth for the quarter that ended in Dec. 2024 was -20.00%.

Impedimed's Earnings per Share (Diluted) for the six months ended in Dec. 2024 was A$-0.01.

Impedimed YoY EPS Growth Historical Data

The historical data trend for Impedimed's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed YoY EPS Growth Chart

Impedimed Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

YoY EPS Growth

Get a 7-Day Free Trial

40.98

52.78

29.41

8.33

9.09

Impedimed Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
YoY EPS Growth	Get a 7-Day Free Trial															-66.67	16.67	50.00	-	-20.00

Impedimed YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Impedimed's YoY EPS Growth for the fiscal year that ended in Jun. 2024 is calculated as:

	YoY EPS Growth (A: Jun. 2024 )
=	(Earnings per Share (Diluted) (A: Jun. 2024 )	-	Earnings per Share (Diluted) (A: Jun. 2023 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2023 ) \|
=	(-0.01	-	-0.011)	/	\| -0.011 \|
=	9.09 %

Impedimed's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EPS Growth (Q: Dec. 2024 )
=	(Earnings per Share (Diluted) (Q: Dec. 2024 )	-	Earnings per Share (Diluted) (Q: Dec. 2023 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2023 )) \|
=	(-0.006	-	-0.005)	/	\| -0.005 \|
=	-20.00 %

Impedimed YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Impedimed's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Impedimed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (ASX:IPD) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

IPDQF:USA

Address

50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008

Website

https://www.impedimed.com

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognizes revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.

Impedimed Headlines

No Headlines